|
Mark Klopp is a Co-founder and Managing Director of Coronis Medical Ventures, a medical device incubator. He also is a partner with The Bell-Mason Group as an advisor to corporations on venturing. Mark is a former board member of the National Venture Capital Association (NVCA) and now serves as outgoing Chairman of the Advisory Board for the Corporate Venture Group. He is a co-founder and board member of Uptake Medical, a medical device company that is treating emphysema.
Formerly Managing Director of Eastman Ventures, Eastman Chemical Company’s corporate venture capital arm, Mark started up and led the company’s efforts to invest in and partner with private companies that brought early access to emerging technology along with creating new growth options for Eastman. He and his team forged relationships and co-investments with premier venture capitalists and corporations. During Mark’s tenure, Eastman invested with a top-quartile IRR track record in 25 ventures and 5 venture funds in areas spanning Information Technology, Life Sciences, Advanced Materials, Energy, and Environmental Technologies.
Mark has extensive operating experience in international business management, sales, and marketing. Prior to leading Eastman Ventures, Mark was the Assistant to Eastman’s CEO and Chairman. He previously headed up the Coatings and Industrial Chemical businesses for Eastman in Europe, the Middle East, and Africa where he was located in The Hague, The Netherlands.
Mark earned a bachelor’s degree in Chemical Engineering from Virginia Tech and his MBA in Management from Roosevelt University.
|
